1. Home
  2. EBS vs VBNK Comparison

EBS vs VBNK Comparison

Compare EBS & VBNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EBS
  • VBNK
  • Stock Information
  • Founded
  • EBS 1998
  • VBNK 1980
  • Country
  • EBS United States
  • VBNK Canada
  • Employees
  • EBS N/A
  • VBNK N/A
  • Industry
  • EBS Biotechnology: Pharmaceutical Preparations
  • VBNK Commercial Banks
  • Sector
  • EBS Health Care
  • VBNK Finance
  • Exchange
  • EBS Nasdaq
  • VBNK Nasdaq
  • Market Cap
  • EBS 423.6M
  • VBNK 398.2M
  • IPO Year
  • EBS 2006
  • VBNK 2021
  • Fundamental
  • Price
  • EBS $9.14
  • VBNK $12.38
  • Analyst Decision
  • EBS Strong Buy
  • VBNK Strong Buy
  • Analyst Count
  • EBS 2
  • VBNK 3
  • Target Price
  • EBS $13.50
  • VBNK $16.00
  • AVG Volume (30 Days)
  • EBS 959.0K
  • VBNK 66.5K
  • Earning Date
  • EBS 11-05-2025
  • VBNK 09-04-2025
  • Dividend Yield
  • EBS N/A
  • VBNK 0.58%
  • EPS Growth
  • EBS N/A
  • VBNK N/A
  • EPS
  • EBS 2.53
  • VBNK 0.69
  • Revenue
  • EBS $851,600,000.00
  • VBNK $82,297,771.00
  • Revenue This Year
  • EBS N/A
  • VBNK $13.07
  • Revenue Next Year
  • EBS $19.24
  • VBNK $41.68
  • P/E Ratio
  • EBS $3.62
  • VBNK $19.41
  • Revenue Growth
  • EBS N/A
  • VBNK 0.07
  • 52 Week Low
  • EBS $4.02
  • VBNK $8.51
  • 52 Week High
  • EBS $12.73
  • VBNK $18.38
  • Technical
  • Relative Strength Index (RSI)
  • EBS 65.40
  • VBNK 55.84
  • Support Level
  • EBS $8.58
  • VBNK $12.11
  • Resistance Level
  • EBS $9.34
  • VBNK $12.83
  • Average True Range (ATR)
  • EBS 0.38
  • VBNK 0.32
  • MACD
  • EBS 0.10
  • VBNK -0.08
  • Stochastic Oscillator
  • EBS 85.94
  • VBNK 30.17

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.

About VBNK VersaBank

VersaBank is a Canadian Schedule I chartered bank with a difference. It has 3 operating segments: Digital Banking Canada, Digital Banking USA and DRTC. It's, cloud-based, business-to-business deposit and lending model provides valued-added solutions to Canadian financial intermediary partners, enabling them to focus on growing their own businesses faster and more profitably. It obtains all of its deposits and provides the majority of its loans and leases electronically, with deposit and lending solutions for financial intermediaries that allow them to excel in their core businesses. In addition, leveraging its internally developed IT security software and capabilities, Company established a wholly owned, subsidiary. Geographically located in Canada and USA.

Share on Social Networks: